Literature DB >> 24066755

Dupilumab in persistent asthma.

Sally E Wenzel, Lin Wang, Gianluca Pirozzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24066755     DOI： 10.1056/NEJMc1309809

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  14 in total

1.  IL-13 desensitizes β2-adrenergic receptors in human airway epithelial cells through a 15-lipoxygenase/G protein receptor kinase 2 mechanism.

Authors:  Giusy D Albano; Jinming Zhao; Emily B Etling; Seo Young Park; Haizhen Hu; John B Trudeau; Mirella Profita; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2015-03-24       Impact factor: 10.793

Review 2.  Update in asthma 2013.

Authors:  Lauren Cohn; Prescott G Woodruff
Journal:  Am J Respir Crit Care Med       Date:  2014-06-15       Impact factor: 21.405

3.  Molecular Mechanisms of Airway Hyperresponsiveness in a Murine Model of Steroid-Resistant Airway Inflammation.

Authors:  Michelle L Manni; Sivanarayana Mandalapu; Kevin J McHugh; M Merle Elloso; Paul L Dudas; John F Alcorn
Journal:  J Immunol       Date:  2016-01-04       Impact factor: 5.422

4.  Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations.

Authors:  Loren C Denlinger; Brenda R Phillips; Sima Ramratnam; Kristie Ross; Nirav R Bhakta; Juan Carlos Cardet; Mario Castro; Stephen P Peters; Wanda Phipatanakul; Shean Aujla; Leonard B Bacharier; Eugene R Bleecker; Suzy A A Comhair; Andrea Coverstone; Mark DeBoer; Serpil C Erzurum; Sean B Fain; Merritt Fajt; Anne M Fitzpatrick; Jonathan Gaffin; Benjamin Gaston; Annette T Hastie; Gregory A Hawkins; Fernando Holguin; Anne-Marie Irani; Elliot Israel; Bruce D Levy; Ngoc Ly; Deborah A Meyers; Wendy C Moore; Ross Myers; Maria Theresa D Opina; Michael C Peters; Mark L Schiebler; Ronald L Sorkness; W Gerald Teague; Sally E Wenzel; Prescott G Woodruff; David T Mauger; John V Fahy; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2017-02-01       Impact factor: 21.405

5.  Combined administration of anti-IL-13 and anti-IL-17A at individually sub-therapeutic doses limits asthma-like symptoms in a mouse model of Th2/Th17 high asthma.

Authors:  Dasom Kim; Jaclyn W McAlees; Lindsay J Bischoff; Davinder Kaur; Lauren K Houshel; Jerilyn Gray; Julie Hargis; Xenia Davis; Paul L Dudas; Hitesh Deshmukh; Ian P Lewkowich
Journal:  Clin Exp Allergy       Date:  2018-11-29       Impact factor: 5.018

6.  Asthma heterogeneity and severity-why is comprehensive phenotyping important?

Authors:  Wendy C Moore; Eugene R Bleecker
Journal:  Lancet Respir Med       Date:  2013-12-23       Impact factor: 30.700

7.  Epigenomic analysis of primary human T cells reveals enhancers associated with TH2 memory cell differentiation and asthma susceptibility.

Authors:  Grégory Seumois; Lukas Chavez; Anna Gerasimova; Matthias Lienhard; Nada Omran; Lukas Kalinke; Maria Vedanayagam; Asha Purnima V Ganesan; Ashu Chawla; Ratko Djukanović; K Mark Ansel; Bjoern Peters; Anjana Rao; Pandurangan Vijayanand
Journal:  Nat Immunol       Date:  2014-07-06       Impact factor: 25.606

Review 8.  Novel Biologicals for the Treatment of Allergic Diseases and Asthma.

Authors:  Hern-Tze Tina Tan; Kazunari Sugita; Cezmi A Akdis
Journal:  Curr Allergy Asthma Rep       Date:  2016-10       Impact factor: 4.806

Review 9.  Severe asthma in children.

Authors:  Theresa W Guilbert; Leonard B Bacharier; Anne M Fitzpatrick
Journal:  J Allergy Clin Immunol Pract       Date:  2014 Sep-Oct

Review 10.  Biological therapies for eosinophilic asthma.

Authors:  Shiven S Patel; Thomas B Casale; Juan Carlos Cardet
Journal:  Expert Opin Biol Ther       Date:  2018-07-04       Impact factor: 4.388
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.